CANC holdings: all 57 positions
CANC held 57 positions as of Oct 13, 2026. Revolution Medicines Inc is the largest at 5.63%; the top 10 are 41.9% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMD | 5.63% |
| 2 | Merck & Co Inc | MRK | 5.44% |
| 3 | Eli Lilly & Co | LLY | 4.85% |
| 4 | Cogent Biosciences Inc | COGT | 4.38% |
| 5 | Novartis AG | NOVN | 3.98% |
| 6 | Genmab A/S (ADR) | GMAB | 3.76% |
| 7 | BeOne Medicines Ltd | ONC | 3.53% |
| 8 | AbbVie Inc | ABBV | 3.51% |
| 9 | Halozyme Therapeutics Inc | HALO | 3.45% |
| 10 | Exelixis Inc | EXEL | 3.41% |
| 11 | Iovance Biotherapeutics Inc | IOVA | 3.36% |
| 12 | Roche Holding AG | RHHBY | 2.81% |
| 13 | Bridgebio Pharma Inc | BBIO | 2.74% |
| 14 | Bristol-Myers Squibb Co | BMY | 2.68% |
| 15 | Ideaya Biosciences Inc | IDYA | 2.49% |
| 16 | CG oncology Inc | CGON | 2.47% |
| 17 | Enliven Therapeutics Inc | ELVN | 2.29% |
| 18 | Immunome Inc | IMNM | 2.28% |
| 19 | Astrazeneca PLC | AZN | 2.18% |
| 20 | Johnson & Johnson | JNJ | 2.14% |
| 21 | Erasca Inc | ERAS | 2.00% |
| 22 | Legend Biotech Corp | LEGN | 1.94% |
| 23 | Relay Therapeutics Inc | RLAY | 1.94% |
| 24 | Zai Lab Ltd | ZLAB | 1.74% |
| 25 | Summit Therapeutics Inc | SMMT | 1.62% |
| 26 | Amgen Inc | AMGN | 1.41% |
| 27 | Celcuity Inc | CELC | 1.32% |
| 28 | Zymeworks Inc | ZYME | 1.27% |
| 29 | Natera Inc | NTRA | 1.24% |
| 30 | ImmunityBio Inc | IBRX | 1.06% |
| 31 | Gilead Sciences Inc | GILD | 1.06% |
| 32 | Kura Oncology Inc | KURA | 1.04% |
| 33 | Arcus Biosciences Inc | RCUS | 1.01% |
| 34 | Nuvation Bio Inc | NUVB | 1.01% |
| 35 | UroGen Pharma Ltd | URGN | 0.98% |
| 36 | Guardant Health Inc | GH | 0.74% |
| 37 | Corvus Pharmaceuticals Inc | CRVS | 0.69% |
| 38 | ORIC Pharmaceuticals Inc | ORIC | 0.66% |
| 39 | Immunocore Holdings PLC | IMCR | 0.66% |
| 40 | Tango Therapeutics Inc | TNGX | 0.64% |
| 41 | Replimune Group Inc | REPL | 0.64% |
| 42 | Inhibrx Biosciences Inc | INBX | 0.62% |
| 43 | Adlai Nortye Group Ltd | ANL | 0.55% |
| 44 | Immatics NV | IMTX | 0.51% |
| 45 | Verastem Inc | VSTM | 0.50% |
| 46 | Moderna Inc | MRNA | 0.50% |
| 47 | Janux Therapeutics Inc | JANX | 0.48% |
| 48 | AnaptysBio Inc | ANAB | 0.44% |
| 49 | Cullinan Therapeutics Inc | CGEM | 0.42% |
| 50 | Candel Therapeutics Inc | CADL | 0.40% |
| 51 | Bicara Therapeutics Inc | BCAX | 0.34% |
| 52 | ArriVent Biopharma Inc | AVBP | 0.30% |
| 53 | Olema Pharmaceuticals Inc | OLMA | 0.29% |
| 54 | CytomX Therapeutics Inc | CTMX | 0.28% |
| 55 | Tyra Biosciences Inc | TYRA | 0.27% |
| 56 | Autolus Therapeutics PLC | AUTL | 0.23% |
| 57 | Arvinas Inc | ARVN | 0.21% |
| Cash and other net assets | 1.61% |
The book
By country
Share of the fund, positions only, as the issuer’s own daily file states them.
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of CANC, data as of Oct 13, 2026. https://etfiq.com/funds/canc/holdings/
ETFIQ. (Oct 13, 2026). Holdings of CANC. Retrieved from https://etfiq.com/funds/canc/holdings/
[Holdings of CANC (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/canc/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.